the aid library

LIST OPTIONS

Filter

686

2023 GINA Main Report, Global Strategy for Asthma Management and Prevention

Global Institute for Asthma (2023) CC2

The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o... more

Download (829)

View PDF (1632)

Quantification of Health Commodities: RMNCH Supplement - Forecasting Consumption of Select Reproductive, Maternal, Newborn, and Child Health Commodities

JSI Research & Training Institute, Inc., and Management Sciences for Health (2016) C1

Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc.... more

Download (326)

View PDF (543)

Bangladesh: Countdown to 2015 - Maternal, Newborn & Child Survival

Countdown to 2030 Commission (2015) C2

The Countdown country profile presents in one place the best and latest evidence to enable an assessment of a country’s progress in improving reproductive, maternal, newborn, and child health (RMNCH)

Download (71)

View PDF (220)

Global Strategy for Asthma Management and Prevention (2022 update)

Global Initiative for Asthma (2022) CC2

The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi... more

Download (833)

View PDF (1397)

India Country Profile 2015

WHO, UNICEF, Countdown to 2015 (2016) C_WHO

Countdown to 2015

Download (985)

View PDF (1689)

Born to Soon. Presentation

Joy Lawn Save the Children; WHO; et al. (2012)

The Global Action Report on Preterm Birth. Presentation

External Link

Tuberculosis in HIV/AIDS Patients - Advanced Techniques in Clinical Microbiology

M. Gjergji; J. Bushati; A. Harxhi; H. Hafizi; P. Pipero iMedPub Journals (2017) C2

Research Article Received: August 21, 2017; Accepted: August 29, 2017; Published: Spetember 05, 2017 This article is available in: http://www.imedpub.com/advanced-techniques-in-clinical-microbiology/

Download (169)

View PDF (177)

Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review

Pan American Health Organisation PAHO (2020) C_WHO

As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I... more

Download (173)

View PDF (166)

Assessment of a revolving drug fund for essential asthma medicines in Benin

Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson, Chen-Yuan Chiang Journal of Pharmaceutical Policy and Practice (2015) C2

Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7 Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma me... more

Download (64)

View PDF (64)

Asthma and pregnancy

National Asthma Education Programme (2012) CC2

Asthma can be a serious disease, but if you understand the disease and take the right medication to control it, you should have no problems or symptoms due to your asthma, even when you are pregnant. To be free from asthma attacks, you should also check your lung function and use an action plan... more

Download (321)

View PDF (589)

Management, control and prevention of tuberculosis - Guidelines for health care providers

Prof. C. Abobltins, L. Brown, Prof N. Curtis, et al. Department of Health & Human Services; State Goverment Victoria (2015) C2

Download (222)

View PDF (349)

Indonesia: Association between sleep quality and obesity in adolescents

N. J. Sagala, S. Sofyani, Supriatmo Paediatrica Indonesiana (2017) C1

Download (232)

View PDF (211)

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.

AIDSinfo; CDC Centers for Disease Control and Prevention; National Institutes of Health; et al. (2019) C2

Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019 Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.

Download (330)

View PDF (510)

Lesotho: Countdown to 2015 - Maternal, Newborn & Child Survival

Countdown to 2030 Commission (2015) C2

Download (178)

View PDF (190)

Guidance on Diagnosis and Management of People with Post-Acute COVID-19 Syndrome
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) C_CDC

This guidance covers diagnosis and care of patients with long-term effects of COVID-19. It makes recommendations for the care of adults and children who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It is meant for health and care practitioners. This interim documen... more

Download (350)

View PDF (629)

Democratic Republic of Congo: PROFILE OF PRETERM AND LOW BIRTH WEIGHT PREVENTION AND CARE

Every Preemie—SCALE (2017) C2

The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme... more

Download (79)

View PDF (76)

Global Strategy for Asthma Management and Prevention (2023 update)

Global Initiative for Asthma (2023) CC2

Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a... more

Download (102)

View PDF (84)

A worldwide charter for all children with asthma

Szefler, S. J.; Fitzgerald, D. A.; Adachi, Y.; (2020) CC2

Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se... more

Download (325)

View PDF (434)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (304)

View PDF (289)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi... more

Guidance on Diagnosis and Management of People with Post-Acute COVID-19 Syndrome recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief recommended

Guidance on Diagnosis and Management of People with Post-Acute COVID-19 Syndrome
recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended